Real-Life Experience Regarding Clinical Characteristics and Treatment Outcome in Non-Cutaneous Peripheral T-Cell Lymphomas: A Multicenter Study of the Turkish Hematology Research and Education Group (ThREG)

Creative Commons License

Kayikci O., MEHTAP Ö., Sari I., DEMİRKAN F., Beyan C., ÇETİN G., ...Daha Fazla

TURKISH JOURNAL OF HEMATOLOGY, cilt.39, sa.3, ss.170-177, 2022 (SCI-Expanded) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 39 Sayı: 3
  • Basım Tarihi: 2022
  • Doi Numarası: 10.4274/tjh.galenos.2022.2022.0052
  • Dergi Adı: TURKISH JOURNAL OF HEMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.170-177
  • Anahtar Kelimeler: Lymphomas, Autologous stem cell transplantation, T-cell lymphomas, Non-Hodgkin lymphoma, HIGH-DOSE CHEMOTHERAPY, AMERICAN SOCIETY, UP-FRONT, TRANSPLANTATION, SURVIVAL, GUIDELINES, PROGNOSIS, DISEASE, COHORT
  • Kocaeli Üniversitesi Adresli: Evet

Özet

Objective: Peripheral T-cell lymphomas (PTCLs) are an uncommon and quite heterogeneous group of disorders, representing only 10%-15% of all non-Hodgkin lymphomas. Although both molecular and clinical studies have increased in recent years, we still have little knowledge regarding real-life practice with PTCLs. In this study, we aimed to investigate the clinical characteristics and treatment outcomes of a large population-based cohort of patients presenting with systemic non-cutaneous PTCL.